Chemical decellularization of porcine liver by two-stage treatment with surfactants and osmoregulators enhances preservation of liver extracellular matrix structure
https://doi.org/10.15825/1995-1191-2025-1-103-113
Abstract
Objective: to develop and investigate a tissue-specific matrix obtained using a modified chemical porcine liver decellularization regime in order to effectively increase preservation of extracellular matrix (ECM) structure, reduce decellularization time and improve purification of the ECM from cellular elements. Materials and methods. Original porcine liver was minced to obtain tissue fragments. Five decellularization regimes were used, with the concentrations and timing of surfactant treatments varied: 0.1% sodium dodecyl sulfate (SDS) and 0.1% or 1% Triton X-100, without and in combination with phosphate-buffered saline (PBS). The glycosaminoglycan (GAG) content of the resulting fragments was determined by lysing the samples for 12 hours in papain solution at +65 °C and then incubating them in 1,9-dimethylmethylene blue. DNA quantification was carried out using DNeasy Blood&Tissue Kit and Quant-iT PicoGreen dye. The morphology of the samples was studied using histological staining techniques. Cytotoxicity of the samples in vitro was evaluated on an NIH/3T3 mouse fibroblast culture by direct contact. Results. Treatment with 0.1% SDS for 2.5 hours with additional treatment with 1% Triton X-100 containing PBS for 21.5 hours (regime 4) increased GAG content to 11.66 ± 0.61 μg/mg compared to 0.68 ± 0.06 μg/mg (regime 5). The DNA content of samples obtained in regime 4 decreased from 99.75 ± 3.93 ng/mg to 14.93 ± 4.91 ng/mg after additional treatment with type I DNase, indicating that cellular components were effectively removed. This matrix showed no cytotoxicity. Conclusion. By optimizing the chemical decellularization regime for porcine liver, we were able to improve preservation of ECM structures, shorten decellularization time and effectively reduce the content of cellular elements. The modified decellularization protocol allowed to obtain a non-cytotoxic tissue-specific matrix with a low potential immunogenicity and a more preserved ECM structure and higher GAG content.
About the Authors
A. D. BelovaRussian Federation
Aleksandra Belova
1, Shchukinskaya str., Moscow, 123182 Phone: (963) 633-94-34
E. A. Nemets
Russian Federation
Moscow
D. D. Filin
Russian Federation
Moscow
A. S. Ponomareva
Russian Federation
Moscow
L. A. Kirsanova
Russian Federation
Moscow
Yu. B. Basok
Russian Federation
Moscow
V. I. Sevastianov
Russian Federation
Moscow
References
1. Dai Q, Jiang W, Huang F, Song F, Zhang J, Zhao H. Recent advances in liver engineering with decellularized scaffold. Front Bioeng Biotechnol. 2022; 10: 831477. doi: 10.3389/fbioe.2022.831477.
2. Zhang X, Chen X, Hong H, Hu R, Liu J, Liu C. Decellularized extracellular matrix scaffolds: Recent trends and emerging strategies in tissue engineering. Bioact Mater. 2021; 10: 15–31. doi: 10.1016/j.bioactmat.2021.09.014.
3. Isaeva EV, Beketov EE, Arguchinskaya NV, Ivanov SА, Shegay PV, Kaprin AD. Decellularized Extracellular Matrix for Tissue Engineering (Review). Sovrem Tekhnologii Med. 2022; 14 (3): 57–68. doi: 10.17691/stm2022.14.3.07.
4. García-Gareta E, Abduldaiem Y, Sawadkar P, Kyriakidis C, Lali F, Greco KV. Decellularised scaffolds: just a framework? Current knowledge and future directions. J Tissue Eng. 2020; 11: 2041731420942903. doi: 10.1177/2041731420942903.
5. Biomimetics of Extracellular Matrices for Cell and Tissue Engineered Medical Products / Ed. V.I. Sevastianov, Yu.B. Basok. Newcastle upon Tyne, UK: Cambridge Scholars Publishing, 2023; 339.
6. Sodhi H, Panitch A. Glycosaminoglycans in tissue engineering: a review. Biomolecules. 2020; 11 (1): 29. doi: 10.3390/biom11010029.
7. Huang Z, Godkin O, Schulze-Tanzil G. The challenge in using mesenchymal stromal cells for recellularization of decellularized cartilage. Stem Cell Rev Rep. 2017; 13 (1): 50–67. doi: 10.1007/s12015-016-9699-8.
8. Neishabouri A, Soltani Khaboushan A, Daghigh F, Kajbafzadeh AM, Majidi Zolbin M. Decellularization in tissue engineering and regenerative medicine: evaluation, modification, and application methods. Front Bioeng Biotechnol. 2022; 10: 805299. doi: 10.3389/fbioe.2022.805299.
9. Jeong W, Kim MK, Kang HW. Effect of detergent type on the performance of liver decellularized extracellular matrix-based bio-inks. J Tissue Eng. 2021; 12: 2041731421997091. doi: 10.1177/2041731421997091.
10. Willemse J, Verstegen MMA, Vermeulen A, Schurink IJ, Roest HP, van der Laan LJW, de Jonge J. Fast, robust and effective decellularization of whole human livers using mild detergents and pressure controlled perfusion. Mater Sci Eng C Mater Biol Appl. 2020; 108: 110200. doi: 10.1016/j.msec.2019.110200.
11. Nemets EA, Malkova AP, Duhina GA, Lazhko AJe, Basok YuB, Kirillova AD, Sevastianov VI. Effect of supercritical carbon dioxide on the in vivo biocompatible and resorptive properties of tissue-specific scaffolds from decellularized pig liver fragments. Promising materials. 2021; 11: 20–31. [In Russ, English abstract]. doi: 10.30791/1028-978X-2021-11-20-31.
12. Gilpin A, Yang Y. Decellularization strategies for regenerative medicine: from processing techniques to applications. Biomed Res Int. 2017; 2017: 9831534. doi: 10.1155/2017/9831534.
13. Syed O, Walters NJ, Day RM, Kim HW, Knowles JC. Evaluation of decellularization protocols for production of tubular small intestine submucosa scaffolds for use in oesophageal tissue engineering. Acta Biomater. 2014; 10 (12): 5043–5054. doi: 10.1016/j.actbio.2014.08.024.
14. Sevastianov VI, Basok YuB, Grigoriev AM, Nemets EA, Kirillova AD, Kirsanova LA et al. Decellularization of cartilage microparticles: Effects of temperature, supercritical carbon dioxide and ultrasound on biochemical, mechanical, and biological properties. J Biomed Mater Res A. 2023; 111 (4): 543–555. doi: 10.1002/jbm.a.37474.
15. Bakhtiar H, Rajabi S, Pezeshki-Modaress M, Ellini MR, Panahinia M, Alijani S et al. Optimizing methods for bovine dental pulp decellularization. J Endod. 2021; 47 (1): 62–68. doi: 10.1016/j.joen.2020.08.027.
16. Kobes JE, Georgiev GI, Louis AV, Calderon IA, Yoshimaru ES, Klemm LM et al. A comparison of iron oxide particles and silica particles for tracking organ recellularization. Mol Imaging. 2018; 17: 1536012118787322. doi: 10.1177/1536012118787322.
17. Kim JK, Koh YD, Kim JO, Seo DH. Development of a decellularization method to produce nerve allografts using less invasive detergents and hyper/hypotonic solutions. J Plast Reconstr Aesthet Surg. 2016; 69 (12): 1690–1696. doi: 10.1016/j.bjps.2016.08.016.
18. Crapo PM, Gilbert TW, Badylak SF. An overview of tissue and whole organ decellularization processes. Biomaterials. 2011; 32 (12): 3233–3243. doi: 10.1016/j.biomaterials.2011.01.057.
19. Suss PH, Ribeiro VST, Motooka CE, de Melo LC, Tuon FF. Comparative study of decellularization techniques to obtain natural extracellular matrix scaffolds of human peripheral-nerve allografts. Cell Tissue Bank. 2022; 23 (3): 511–520. doi: 10.1007/s10561-021-09977-x.
20. Nemets EA, Kirsanova LA, Basok JB, Schagidulin MJ, Volkova EA, Metelsky ST, Sevastianov VI. Technology features of decellularization of human liver fragments as tissuespecific fine-grained matrix for cell-engineering liver construction. Russian Journal of Transplantology and Artificial Organs. 2017; 19 (4): 70–77. [In Russ, English abstract]. doi: 10.15825/1995-1191-2017-4-70-77.
21. Kirillova AD, Basok YB, Lazhko AE, Grigoryev AM, Kirsanova LA, Nemets EA, Sevastianov VI. Creating a tissue-specific microdispersed matrix from a decellularized porcine liver. Physics and Chemistry of Materials Processing. 2020; 4: 41–50. [In Russ, English abstract]. doi: 10.30791/0015-3214-2020-4-41-50.
22. GOST ISO 10993-5-2011. Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity. M.: Standartinform, 2014; 9.
23. Gordillo M, Evans T, Gouon-Evans V. Orchestrating liver development. Development. 2015; 142 (12): 2094– 2108. doi: 10.1242/dev.114215.
24. Zhou J, Fritze O, Schleicher M, Wendel HP, SchenkeLayland K, Harasztosi C et al. Impact of heart valve decellularization on 3-D ultrastructure, immunogenicity andthrombogenicity. Biomaterials. 2010; 31 (9): 2549– 2554. doi: 10.1016/j.biomaterials.2009.11.088.
25. O’Neill JD, Anfang R, Anandappa A, Costa J, Javidfar J, Wobma HM et al. Decellularization of human and porcine lung tissues for pulmonary tissue engineering. Ann Thorac Surg. 2013; 96 (3): 1046–1056. doi: 10.1016/j.athoracsur.2013.04.022.
26. Sullivan DC, Mirmalek-Sani SH, Deegan DB, Baptista PM, Aboushwareb T, Atala A, Yoo JJ. Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system. Biomaterials. 2012; 33 (31): 7756–7764. doi: 10.1016/j.biomaterials.2012.07.023.
Supplementary files
Review
For citations:
Belova A.D., Nemets E.A., Filin D.D., Ponomareva A.S., Kirsanova L.A., Basok Yu.B., Sevastianov V.I. Chemical decellularization of porcine liver by two-stage treatment with surfactants and osmoregulators enhances preservation of liver extracellular matrix structure. Russian Journal of Transplantology and Artificial Organs. 2025;27(1):103-113. https://doi.org/10.15825/1995-1191-2025-1-103-113